168 related articles for article (PubMed ID: 6231139)
1. Heparan sulfate and dermatan sulfate from the liver of a patient with Hurler syndrome: high performance liquid chromatography of their degradation products after incubation with alpha-L-iduronidase-deficient fibroblasts.
Minami R; Fujibayashi S; Igarashi C; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
Clin Chim Acta; 1984 Feb; 137(2):179-87. PubMed ID: 6231139
[TBL] [Abstract][Full Text] [Related]
2. Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.
Fujibayashi S; Minami R; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
Hum Genet; 1984; 65(3):268-72. PubMed ID: 6421718
[TBL] [Abstract][Full Text] [Related]
3. alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate.
Muller VJ; Hopwood JJ
Clin Genet; 1984 Nov; 26(5):414-21. PubMed ID: 6437709
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical characterization of canine alpha-L-iduronidase deficiency disease (model of human mucopolysaccharidosis I).
Constantopoulos G; Shull RM; Hastings N; Neufeld EF
J Neurochem; 1985 Oct; 45(4):1213-7. PubMed ID: 3928817
[TBL] [Abstract][Full Text] [Related]
5. Selective depolymerisation of dermatan sulfate: production of radiolabelled substrates for alpha-L-iduronidase, sulfoiduronate sulfatase, and beta-D-glucuronidase.
Hopwood JJ; Muller VJ
Carbohydr Res; 1983 Oct; 122(2):227-39. PubMed ID: 6423280
[TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Fuller M; Meikle PJ; Hopwood JJ
Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
[TBL] [Abstract][Full Text] [Related]
7. A canine model of human alpha-L-iduronidase deficiency.
Spellacy E; Shull RM; Constantopoulos G; Neufeld EF
Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6091-5. PubMed ID: 6412235
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dermatan sulfate in mucopolysaccharidosis VI. Evidence for the absence of hyaluronidase-like enzymes in human skin fibroblasts.
Klein U; von Figura K
Biochim Biophys Acta; 1980 Jun; 630(1):10-4. PubMed ID: 6770909
[TBL] [Abstract][Full Text] [Related]
9. Clinical ultrastructural and tissue culture studies in a possible compound Hurler-Scheie case.
Tondeur M; Vamos-Hurwitz E; Cantz M; Cremer N; Libert J; Pardou A
Acta Paediatr Belg; 1976; 29(2):109-15. PubMed ID: 826105
[No Abstract] [Full Text] [Related]
10. Proceedings: Alpha-L-iduronidase deficiency associated with chondroitin sulphate mucopolysaccharidosis.
Babarik A; Benson PF; Dean MF; Muir H
Arch Dis Child; 1975 Apr; 50(4):329-30. PubMed ID: 807169
[No Abstract] [Full Text] [Related]
11. Absence of alpha-L-iduronidase activity in various tissues from two sibs affected with presumably the Hurler-Scheie compound syndrome.
Thompson JN; Finley SC; Lorincz AE; Finley WH
Birth Defects Orig Artic Ser; 1975; 11(6):341-6. PubMed ID: 811284
[No Abstract] [Full Text] [Related]
12. The heterogeneity of dermatan sulfate and heparan sulfate in rat liver and a shift in the glycosaminoglycan contents in carbon tetrachloride-damaged liver.
Suzuki S; Suzuki S; Nakamura N; Koizumi T
Biochim Biophys Acta; 1976 Mar; 428(1):166-181. PubMed ID: 130930
[TBL] [Abstract][Full Text] [Related]
13. Dyggve-Melchior-Clausen syndrome: normal degradation of proteodermatan sulfate, proteokeratan sulfate and heparan sulfate.
Beck M; Lücke R; Kresse H
Clin Chim Acta; 1984 Aug; 141(1):7-15. PubMed ID: 6235983
[TBL] [Abstract][Full Text] [Related]
14. The mucopolysaccharidoses (a review).
Dorfman A; Matalon R
Proc Natl Acad Sci U S A; 1976 Feb; 73(2):630-7. PubMed ID: 813230
[TBL] [Abstract][Full Text] [Related]
15. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry.
Kubaski F; Mason RW; Nakatomi A; Shintaku H; Xie L; van Vlies NN; Church H; Giugliani R; Kobayashi H; Yamaguchi S; Suzuki Y; Orii T; Fukao T; Montaño AM; Tomatsu S
J Inherit Metab Dis; 2017 Jan; 40(1):151-158. PubMed ID: 27718145
[TBL] [Abstract][Full Text] [Related]
16. Characterization of glycosaminoglycans stored in mucopolysaccharidosis III A: evidence for a generally occuring degradation of heparan sulfate by endoglycosidases.
Kindler A; Klein U; von Figura K
Hoppe Seylers Z Physiol Chem; 1977 Nov; 358(11):1431-8. PubMed ID: 411726
[TBL] [Abstract][Full Text] [Related]
17. Newborn screening and diagnosis of mucopolysaccharidoses.
Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
[TBL] [Abstract][Full Text] [Related]
18. Sulfated glycosaminoglycans of cells grown in culture: dermatan sulfate disappearance in successive fibroblast subcultures.
Mourão PA; Machado-Santelli GM
Cell Differ; 1978 Dec; 7(6):367-74. PubMed ID: 737741
[TBL] [Abstract][Full Text] [Related]
19. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Zhang H; Wood T; Young SP; Millington DS
Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
[TBL] [Abstract][Full Text] [Related]
20. Fluorometric measurement of urinary alpha-L-iduronidase activity.
Isemura M; Kosaka H; Ikenaka T; Kido R; Yoshimura T
J Biochem; 1978 Sep; 84(3):627-32. PubMed ID: 102641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
